KR20220004643A - 신규 의약 조성물 - Google Patents

신규 의약 조성물 Download PDF

Info

Publication number
KR20220004643A
KR20220004643A KR1020217034629A KR20217034629A KR20220004643A KR 20220004643 A KR20220004643 A KR 20220004643A KR 1020217034629 A KR1020217034629 A KR 1020217034629A KR 20217034629 A KR20217034629 A KR 20217034629A KR 20220004643 A KR20220004643 A KR 20220004643A
Authority
KR
South Korea
Prior art keywords
citric acid
pharmaceutical composition
administration
weeks
anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217034629A
Other languages
English (en)
Korean (ko)
Inventor
미치아키 아베
세이조 고시바
고이치로 니시오카
가즈히코 가와구치
사토미 야마사키
야스유키 데라나카
Original Assignee
고쿠리츠다이가쿠호진 도호쿠다이가쿠
닛뽕 케미파 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고쿠리츠다이가쿠호진 도호쿠다이가쿠, 닛뽕 케미파 가부시키가이샤 filed Critical 고쿠리츠다이가쿠호진 도호쿠다이가쿠
Publication of KR20220004643A publication Critical patent/KR20220004643A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020217034629A 2019-04-28 2020-04-24 신규 의약 조성물 Ceased KR20220004643A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019086945 2019-04-28
JPJP-P-2019-086945 2019-04-28
JP2019119297 2019-06-27
JPJP-P-2019-119297 2019-06-27
PCT/JP2020/017690 WO2020222302A1 (ja) 2019-04-28 2020-04-24 新規医薬組成物

Publications (1)

Publication Number Publication Date
KR20220004643A true KR20220004643A (ko) 2022-01-11

Family

ID=73028960

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217034629A Ceased KR20220004643A (ko) 2019-04-28 2020-04-24 신규 의약 조성물

Country Status (7)

Country Link
US (1) US20220202752A1 (https=)
EP (1) EP3964264A4 (https=)
JP (1) JPWO2020222302A1 (https=)
KR (1) KR20220004643A (https=)
AU (1) AU2020267068A1 (https=)
CA (1) CA3137691A1 (https=)
WO (1) WO2020222302A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7219898B2 (ja) * 2017-04-18 2023-02-09 国立大学法人東北大学 アルカリ性化剤による血液浄化

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018193648A1 (ja) 2017-04-18 2018-10-25 国立大学法人東北大学 アルカリ性化剤による血液浄化

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4722492B2 (ja) * 2005-01-11 2011-07-13 日本メナード化粧品株式会社 鉄欠乏性貧血に伴う不定愁訴の予防又は改善剤。
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
EP2194977A1 (en) * 2007-08-31 2010-06-16 C.B. Fleet Company Incorporated Method of preventing nephrocalcinosis
MX357998B (es) * 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
CA3010771A1 (en) * 2016-01-06 2017-07-13 Rockwell Medical, Inc. Combination therapy with an iron compound and a citrate compound
JP7578234B2 (ja) * 2017-04-18 2024-11-06 国立大学法人東北大学 アルカリ性化剤による血液浄化
JP6296410B1 (ja) 2017-11-06 2018-03-20 株式会社ＤａｔａＳｉｇｎ 利用サービス管理装置
JP6810683B2 (ja) 2017-12-28 2021-01-06 本田技研工業株式会社 制御装置および車両
AU2019361520B2 (en) * 2018-10-17 2025-04-24 Nippon Chemiphar Co., Ltd. Novel pharmaceutical composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018193648A1 (ja) 2017-04-18 2018-10-25 国立大学法人東北大学 アルカリ性化剤による血液浄化
WO2018193752A1 (ja) 2017-04-18 2018-10-25 国立大学法人東北大学 アルカリ性化剤による血液浄化

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Brito-Ashurst, I. D., et al. : Bicarbonate supplementation slows progression of CKD and improves nutritional status. J. Am. Soc. Nephrol., 20 : 2075 - 2084, 2009.
Souma T., et al. : Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J. Am. Soc. Nephrol., 22 : 635 - 648, 2011.

Also Published As

Publication number Publication date
AU2020267068A1 (en) 2021-11-18
EP3964264A4 (en) 2023-07-12
CA3137691A1 (en) 2020-11-05
EP3964264A1 (en) 2022-03-09
US20220202752A1 (en) 2022-06-30
JPWO2020222302A1 (https=) 2020-11-05
WO2020222302A1 (ja) 2020-11-05

Similar Documents

Publication Publication Date Title
KR102773144B1 (ko) 시트르산의 의약적으로 허용 가능한 염, 혹은 그 수화물 또는 그들의 혼합물을 포함하는 의약 조성물
US12324793B2 (en) Method for renal protection
JP2011098896A (ja) 尿酸値低下用組成物
JP2023115271A (ja) アルカリ性化剤による血液浄化
JP2026063342A (ja) 腎機能保護剤
KR20220004643A (ko) 신규 의약 조성물
CA3116695A1 (en) Inhibitor of renal fibrosis in diabetic nephropathy
CN103813792A (zh) 用于治疗膀胱过度活动症的索利那新和唾液刺激剂的组合
TW202308604A (zh) 肌肉量增加用組成物
WO2025206119A1 (ja) 治療前の尿アルブミン濃度が特定の範囲である慢性腎臓病の治療のための医薬組成物
EA018442B1 (ru) Применение l-карнитина для лечения гипертензии, для снижения систолического или пульсового давления крови у субъектов с предиабетом
HK40056055A (en) Novel pharmaceutical composition
JP6691971B2 (ja) 慢性骨髄性白血病を治療又は寛解するための医薬組成物
HK40055117A (en) Inhibitor of renal fibrosis in diabetic nephropathy

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601